Uterine Leiomyosarcoma Prognosis
Uterine leiomyosarcoma is a rare type of uterine cancer. Uterine sarcomas make up only 2 to 4 percent of all uterine cancers, and leiomyosarcomas are a subtype of uterine sarcomas. African American women are especially prone to getting uterine leiomyosarcoma, for reasons not known. The average age for a women to be diagnosed with uterine leiomyosarcoma is 50, according to the National Cancer Institute.
Aggressive Cancer
Uterine leiomyosarcoma is believed to be a more aggressive cancer than carcinosarcomas but can be cured through surgery if the cancer is limited to the uterus.
Tumor Size
One of the most important factors in determining the prognosis is the tumor size, according to the National Cancer Institute. A tumor bigger than five centimeters has a poor prognosis.
Diagnosis Timing
For any uterine sarcoma, the prognosis is heavily dependent on what stage the disease is at when first diagnosed. The sooner the disease is caught, the better the prognosis.
Prognosis Stage 1
The five-year survival rate for women who are diagnosed with stage 1 uterine leiomyosarcoma is 50 percent, according to the National Cancer Institute.
Other Prognoses
For women at stages 2 to 4, the prognosis is significantly worse. It is 0 to 20 percent for the five-year survival rate.
Tags: according National, according National Cancer, Cancer Institute, National Cancer, National Cancer Institute
